pargyline has been researched along with Respiratory Insufficiency in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Respiratory Insufficiency: Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simpson, LL | 1 |
| Tapp, JT | 1 |
1 other study available for pargyline and Respiratory Insufficiency
| Article | Year |
|---|---|
Partial antagonism of experimental botulinal intoxication.
Topics: Animals; Antitoxins; Calcium; Clostridium botulinum; Diaphragm; Drug Antagonism; Female; In Vitro Te | 1967 |